RAFFAELLA BELVEDERE | Curriculum

QUALIFICATIONS AND PROFESSIONAL EXPERIENCE

2024-present RTD B (SSD BIOS 11/A) at DIFARMA; UNISA

2023-2024 RTD A (SSD BIO/14) at DIFARMA; UNISA.

2020-2023 Research fellow (type A) on the project ‘Effects of mesoglycan in tissue repair’ (Head: prof. Antonello Petrella) financed with University funds 2019, and on the project of Realization of Patent Valorization Programs through the Funding of Proof of Concept (PoC) Projects of the Ministry of Economic Development (Valorization Program #NOACRONYM).

2019-2020 Research fellow on projects ‘Study of annexin A1 in tumor progression’ (Head: prof. Antonello Petrella) as part of the research project ‘Fighting tumor resistance: multidisciplinary integrated platform for an innovative technological approach to oncotherapies’, POR Campania FESR 2014-2020, and ‘Role of heparinoids in tissue repair’ (Head: prof. Antonello Petrella) within the research project ‘Integrated biotechnologies for integrative and personalized therapies of oncological and cardiovascular diseases OCKEY’, POR Campania FESR 2007-2013.

2016-2019 Research fellow (type B) on the project ‘Study of the in vitro efficacy of the Prisma® Skin biomedical device in the treatment of skin lesions’ (Head: prof. Antonello Petrella) funded by Mediolanum Farmaceutici S.p.a.

11.2014-02.2015 Visiting PhD student at the Oncology Research Laboratory, Tumores digestivos section, supervised by Dr. Manuel Hidalgo; CNIO (Centro Nacional de Investigationes Oncològicas), Madrid, Spain.

2013-2016 PhD Course in ‘Systems Biology’, XIV cycle, at the Laboratory of Pharmacology, project entitled ‘Role of Annexin A1 in tumor progression’.

2011 Master’s degree in chemistry and Pharmaceutical Technologies (110/110 cum laude), University of Salerno.

SCIENTIFIC RESPONSIBILITY

Scientific co-responsible, together with prof. Antonello Petrella, of a scientific collaboration agreement between Neilos s.r.l. and DIFARMA entitled: ‘Evaluation of the efficacy of substances with antimicrobial activity for skin and mucosae in tissue repair’ (2021-2022).

RESEARCH ACTIVITIES AND AREAS OF INTEREST

The research activity mainly concerns the molecular mechanisms involved in cell regeneration within the repair process of skin lesions and neoplastic progression as targets for the development of new pharmacological treatments.

- Study of glycosaminoglycans (mainly mesoglycan) in tissue repair.

- Study of the role of annexin A1 protein in the tumor progression of pancreatic carcinoma.

- Study of the role of annexin A1 and CAF-1 proteins and the effects of metformin in head and neck cancer.

AWARDS FOR RESEARCH ACTIVITY

2018 - SIF-Farmindustria Award for pharmacological research instituted by the Italian Society of Pharmacology and Farmindustria

ACTIVITIES SUPPORTING TECHNOLOGY TRANSFER PROCESSES

Patent No. 102018000010968- COMPOSITION FOR THE TREATMENT OF CUTANEOUS LESIONS - UNIVERSITY OF SALERNO Application granted on 30 October 2020

Application No. PCT/IB2019/060595: Extension as PCT patent 10-12-2019